SCHEMBL21972253

SCHEMBL21972253

Cc1ccccc1C1N(C)c2cc(N(C)C)c(N(C)C)cc2N1C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 1/20 0.40
▸ LMNA P02545 2/20 0.38
▸ GAA P10253 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PABPC1 P11940 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MAPT P10636 1/20 0.32
▸ HTR2C P28335 3/20 0.32
▸ HTR2A P28223 2/20 0.32
▸ HTR2B P41595 2/20 0.32
▸ HRH3 Q9Y5N1 2/20 0.32
▸ HDAC4 P56524 2/20 0.32
▸ MAOA P21397 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC5 Q9UQL6 1/20 0.32
▸ GPR3 P46089 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21970632 0.86 PDGFRB (0.42) PDGFRBLMNAGAAKDM4EALDH1A1
SCHEMBL21972264 0.80 LMNA (0.53) PDGFRBLMNAALDH1A1NPSR1MAPT
SCHEMBL21970984 0.77 PDGFRB (0.56) PDGFRBLMNAGAAKDM4EALDH1A1
SCHEMBL20508364 0.75 PDGFRB (0.53) PDGFRBLMNAGAAKDM4EALDH1A1
SCHEMBL21970991 0.73 PDGFRB (0.51) PDGFRBLMNAGAAKDM4EALDH1A1
SCHEMBL21972256 0.72 PDGFRB (0.50) PDGFRBLMNAGAAKDM4EALDH1A1
SCHEMBL21972254 0.72 PDGFRB (0.42) PDGFRBHTR2CHDAC4MAOB
SCHEMBL21971402 0.70 PDGFRB (0.47) PDGFRBLMNAGAAKDM4EALDH1A1
SCHEMBL21971408 0.70 PDGFRB (0.47) PDGFRBLMNAGAAKDM4EALDH1A1
SCHEMBL20739540 0.69 PDGFRB (0.69) PDGFRBGAAKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046655-B2 Compound and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME CBR3, NR2E3, NR5A2 PDGFRB 2517/4885LMNA 4733/4885GAA 4816/4885
US-11046655-B2 Compound and method for producing same CBR3, NR5A1, NR2E3 PDGFRB 2499/4885LMNA 4570/4885GAA 4803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback